MarketScreener Editorial Features Daiichi Sankyo Company, Limited
Equities
4568
JP3475350009
Pharmaceuticals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,950.50 JPY | -0.15% |
|
-0.05% | -11.87% |
MarketScreener Editorial Features
Search
| AstraZeneca and Daiichi Sankyo's Enhertu approved as first-line therapy for HER2+ breast cancer | December 16, 2025 at 07:35 am | |
![]() | America in a Holding Pattern | August 18, 2025 at 02:05 pm |
| Donald Trump deals another blow to Big Pharma | May 12, 2025 at 03:17 pm | |
| Global markets live: Apple, Johnson & Johnson, Meta, Amazon, The Hershey, Eli Lilly... | January 13, 2025 at 04:04 pm | |
![]() | Daiichi Sankyo: Voluntary withdrawal of MAA in the EU for Dato-DXd | December 31, 2024 at 12:23 pm |
| Global markets live: Airbus, HSBC, Boeing, Microsoft, Starbucks... | July 31, 2024 at 05:11 pm | |
| Global markets live: IAG, Credit Suisse, Foxconn, General Motors, Blackstone... | October 31, 2022 at 04:13 pm | |
![]() | MarketScreener's World Press Review : June 6, 2022 | June 07, 2022 at 01:20 pm |
![]() | MarketScreener's World Press Review : June 6, 2022 | June 06, 2022 at 11:15 am |
No results for this search
Filters
- Stock Market
- Equities
- 4568 Stock
- News Daiichi Sankyo Company, Limited
- MarketScreener Editorial Features
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition




















